NO965516L - Sterolderivater anvendt til regulering av meiose - Google Patents

Sterolderivater anvendt til regulering av meiose

Info

Publication number
NO965516L
NO965516L NO965516A NO965516A NO965516L NO 965516 L NO965516 L NO 965516L NO 965516 A NO965516 A NO 965516A NO 965516 A NO965516 A NO 965516A NO 965516 L NO965516 L NO 965516L
Authority
NO
Norway
Prior art keywords
sterol derivatives
derivatives used
regulate meiosis
meiosis
regulate
Prior art date
Application number
NO965516A
Other languages
English (en)
Other versions
NO965516D0 (no
NO314534B1 (no
Inventor
Anne Grete Byskov
Claus Yding Andersen
Lars Nordholm
Henning Thoegersen
Ole Wassmann
Ivan Verner Diers
Erling Guddal
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO965516D0 publication Critical patent/NO965516D0/no
Publication of NO965516L publication Critical patent/NO965516L/no
Publication of NO314534B1 publication Critical patent/NO314534B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
NO19965516A 1994-06-23 1996-12-20 Anvendelse av sterolderivater til fremstilling av et preparat for regulering av meiose, forbindelser for anvendelse som terapeutika ogfremgangsmåte for regulering av meiose i en pattedyrkjönnscelle in vitro NO314534B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK75394 1994-06-23
DK24195 1995-03-09
PCT/DK1995/000265 WO1996000235A1 (en) 1994-06-23 1995-06-23 Sterol derivatives used for regulation of meiosis

Publications (3)

Publication Number Publication Date
NO965516D0 NO965516D0 (no) 1996-12-20
NO965516L true NO965516L (no) 1997-02-21
NO314534B1 NO314534B1 (no) 2003-04-07

Family

ID=26063596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19965516A NO314534B1 (no) 1994-06-23 1996-12-20 Anvendelse av sterolderivater til fremstilling av et preparat for regulering av meiose, forbindelser for anvendelse som terapeutika ogfremgangsmåte for regulering av meiose i en pattedyrkjönnscelle in vitro

Country Status (26)

Country Link
US (1) US5716777A (no)
EP (1) EP0767798B1 (no)
JP (1) JP3987105B2 (no)
KR (1) KR100408369B1 (no)
CN (1) CN1068333C (no)
AT (1) ATE248852T1 (no)
AU (1) AU694240B2 (no)
BG (1) BG101067A (no)
BR (1) BR9508074A (no)
CA (1) CA2192941C (no)
CZ (1) CZ289407B6 (no)
DE (1) DE69531682T2 (no)
DK (1) DK0767798T3 (no)
ES (1) ES2204955T3 (no)
FI (1) FI117159B (no)
HU (1) HUT76343A (no)
IL (1) IL114294A (no)
IS (1) IS4404A (no)
MX (1) MX9700174A (no)
NO (1) NO314534B1 (no)
PL (1) PL186688B1 (no)
RU (1) RU2194510C2 (no)
SI (1) SI9520077A (no)
SK (1) SK165596A3 (no)
UA (1) UA51622C2 (no)
WO (1) WO1996000235A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ279797A3 (cs) * 1995-03-06 1998-01-14 Novo Nordisk A/S Způsob stimulace miózy zárodečné buňky a použití sloučeniny, která způsobuje akumulaci látky aktivující endogenní miózu
BR9608968A (pt) * 1995-06-23 1999-06-29 Novo Nordisk As Composto e processo para regular meiose em uma célula germinativa de mamífero
US6645953B2 (en) * 1995-06-23 2003-11-11 Novo Nordisk A/S Meiosis regulating compounds
AU6122696A (en) * 1995-06-23 1997-01-22 Novo Nordisk A/S Meiosis regulating compounds
JP2001506656A (ja) 1996-12-20 2001-05-22 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
CN1260802A (zh) * 1997-05-16 2000-07-19 阿克佐诺贝尔公司 20－芳烷基－5α－孕甾烷衍生物
CA2289524A1 (en) * 1997-06-04 1998-12-10 Akzo Nobel Nv 17.beta.-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
DK1042353T3 (da) 1997-12-18 2002-11-04 Akzo Nobel Nv 17-beta-aryl(arylmethyl)oxy(thio)alkylandrostanderivater
CA2331962A1 (en) * 1998-05-13 1999-11-18 Novo Nordisk A/S Meiosis regulating compounds
IL139241A0 (en) * 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
JP2002516272A (ja) * 1998-05-26 2002-06-04 シエーリング アクチエンゲゼルシヤフト ｃＡＭＰを増大させる化合物を単独でまたは減数分裂を刺激する少なくとも１つの化合物との組合せ物での不妊治療
IL140216A0 (en) * 1998-06-19 2002-02-10 Novo Nordisk As Meiosis regulating compounds
EP1137660B1 (en) * 1998-12-11 2002-10-02 Akzo Nobel N.V. 22s-hydroxycholesta-8,14-diene derivatives with meiosis regulating activity
WO2000036132A1 (en) 1998-12-14 2000-06-22 Merck & Co., Inc. Hiv integrase inhibitors
BR0008065A (pt) * 1999-02-10 2001-11-06 Schering Aktiengellschaft Derivados de colestano insaturados e seu uso para a preparação de medicamentos que regulam meiose
EP1156822B1 (en) * 1999-02-24 2006-02-08 Novo Nordisk A/S Iin vitro method for synchronisation of oocyte maturation
EP1156821B1 (en) * 1999-02-24 2007-05-02 Novo Nordisk A/S Treatment of infertility
CN1341147A (zh) * 1999-02-26 2002-03-20 诺沃挪第克公司 减数分裂活化甾醇增大着床率
AU3285000A (en) * 1999-03-09 2000-09-28 Akzo Nobel N.V. 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
IL148234A0 (en) * 1999-09-16 2002-09-12 Novo Nordisk As Composition for ivf
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
AU3376501A (en) * 2000-02-25 2001-09-03 Novo Nordisk A/S Improvement of implantation rate
AU2001240624A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Improvement of implantation rate
WO2001088098A2 (en) * 2000-05-18 2001-11-22 Schering Aktiengesellschaft Fertilization of aged oocytes
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
AU2003203145A1 (en) * 2002-02-22 2003-09-09 Novo Nordisk A/S A transducer of mas signalling
WO2012044817A2 (en) * 2010-10-01 2012-04-05 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from ganoderma lucidum and analogs thereof
US9165822B2 (en) 2013-03-11 2015-10-20 Taiwan Semiconductor Manufacturing Company, Ltd. Semiconductor devices and methods of forming same
EA024619B1 (ru) * 2014-11-21 2016-10-31 Эльвин Гаджи оглы Керимли ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ

Also Published As

Publication number Publication date
PL317830A1 (en) 1997-04-28
DE69531682T2 (de) 2004-07-15
FI965144A (fi) 1997-02-20
IL114294A (en) 2002-09-12
DE69531682D1 (de) 2003-10-09
ATE248852T1 (de) 2003-09-15
RU2194510C2 (ru) 2002-12-20
IS4404A (is) 1996-12-23
CZ372596A3 (en) 1997-07-16
CA2192941C (en) 2009-04-14
AU694240B2 (en) 1998-07-16
CA2192941A1 (en) 1996-01-04
BG101067A (en) 1997-08-29
BR9508074A (pt) 1997-08-12
CN1151164A (zh) 1997-06-04
JP3987105B2 (ja) 2007-10-03
EP0767798A1 (en) 1997-04-16
MX9700174A (es) 1997-04-30
CZ289407B6 (cs) 2002-01-16
HUT76343A (en) 1997-08-28
SI9520077A (sl) 1998-06-30
UA51622C2 (uk) 2002-12-16
AU2734395A (en) 1996-01-19
NO965516D0 (no) 1996-12-20
KR100408369B1 (ko) 2004-04-28
DK0767798T3 (da) 2003-12-22
JPH10502060A (ja) 1998-02-24
IL114294A0 (en) 1995-10-31
WO1996000235A1 (en) 1996-01-04
SK165596A3 (en) 1997-08-06
HU9603584D0 (en) 1997-02-28
ES2204955T3 (es) 2004-05-01
NO314534B1 (no) 2003-04-07
PL186688B1 (pl) 2004-02-27
FI117159B (fi) 2006-07-14
FI965144A0 (fi) 1996-12-20
CN1068333C (zh) 2001-07-11
EP0767798B1 (en) 2003-09-03
US5716777A (en) 1998-02-10

Similar Documents

Publication Publication Date Title
NO965516D0 (no) Sterolderivater anvendt til regulering av meiose
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
IT1285770B1 (it) Composti corticoidei
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
FI972387A (fi) Iholle levitettäviä parasitisidikoostumuksia
MX9700885A (es) Nuevas heteroariloxazolidinonas.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE231872T1 (de) Thiazolopyrimidinderivate
DK0425650T3 (da) Antiinflammatoriske 4-aminophenolderivater
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
SE9801494D0 (sv) Novel use
ES2188908T3 (es) Derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes relacionados con el estrogenos.
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
ATE227122T1 (de) Stabilisierte tablettenformulierung
FI923751A (fi) Hexahydrobenso/f/kinolinoner
ES2191170T3 (es) Nuevos (-)-enantiomeros de derivados de cis-3,4-cromano utiles en la prevencion y tratamiento de sindromes o enfermedades relacionadas con el estrogeno.
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
DK0720597T3 (da) Triarylethylenderivater til terapeutisk anvendelse
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
DK0967986T3 (da) Anvendelse af humant alfa1-surt glycoprotein til fremstilling af et farmaceutisk præparat